Longeveron (LGVN) Deferred Taxes (2020 - 2023)
Longeveron (LGVN) recorded quarterly Deferred Taxes of -$1.3 million in Q2 2023, down 2596.0% quarter-over-quarter from -$50000.0 in Q1 2023, and down 8886.67% on a YoY basis from $15341.4 in Q2 2022.
Longeveron (LGVN) Deferred Taxes (2020 - 2023) Analysis & Trends
Longeveron's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$1.3 million for Q2 2023.
- In Q2 2023, Deferred Taxes fell 8886.67% year-over-year to -$1.3 million; the TTM figure through Dec 2023 stood at -$1.4 million (changed N/A YoY), while the FY2023 annual figure was -$1.4 million, down 355.37% from the prior year.
- Deferred Taxes was -$1.3 million for Q2 2023 at Longeveron, down from -$50000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $339000.0 in Q2 2020 to a low of -$1.3 million in Q2 2023.
- Historically, Deferred Taxes has averaged -$114583.3 across 4 years, with a median of -$5500.0 in 2021.
- The sharpest annual moves came in 2021 and 2023: Deferred Taxes soared 113.86% in 2021, then plunged 8886.67% in 2023.
- A 4-year view of Deferred Taxes shows it stood at $232000.0 in 2020, then plunged by 98.28% to $4000.0 in 2021, then slumped by 475.0% to -$15000.0 in 2022, then slumped by 8886.67% to -$1.3 million in 2023.
- The last three Deferred Taxes figures came in at -$1.3 million (Q2 2023), -$50000.0 (Q1 2023), and -$15000.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Longeveron | 20.35 Bn | 20.33 Bn | 264,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -1.35 Mn |
| Mar 31, 2023 | -50,000.00 |
| Jun 30, 2022 | -15,000.00 |
| Mar 31, 2022 | -306,000.00 |
| Dec 31, 2021 | 4,000.00 |
| Sep 30, 2021 | 28,000.00 |
| Jun 30, 2021 | 155,000.00 |
| Mar 31, 2021 | -375,000.00 |
| Dec 31, 2020 | 232,000.00 |
| Sep 30, 2020 | -202,000.00 |
| Jun 30, 2020 | 339,000.00 |
| Mar 31, 2020 | 163,000.00 |